Discover
MCRB
Seres Therapeutics, Inc.
7.94
2 x 5.64
2 x 9.81
bid
ask
+
0.05
0.63%
2 @ 04:00 PM
7.94 +0.00 (0.00%)
| Ytd | -46.64% | |
| 1y | -25.79% |
7.63
day range
8.00
5.31
52 week range
29.98
| Open | 7.82 | Prev Close | 7.89 | Low | 7.63 | High | 8.00 | Mkt Cap | 76.89M |
| Vol | 150.63K | Avg Vol | 69.88K | EPS | -5.20 | P/E | N/A | Forward P/E | -1.75 |
| Beta | 2.05 | Short Ratio | 5.18 | Inst. Own | 37.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 7.31 | 200-d Avg | 12.63 | 1yr Est | 3.87 |
| Income Statement | |||
| Total Revenue | 358.00K | ||
| Revenues (USD) | 358.00K | ||
| Gross Profit | 358.00K | ||
| Operating Expenses | 21.27M | ||
| Research and Development Expense | 13.20M | ||
| Selling, General and Administrative Expense | 8.07M | ||
| Operating Income | -20.91M | ||
| Net Income | -19.91M | ||
| Net Income Common Stock | -19.91M | ||
| Net Income Common Stock (USD) | -19.91M | ||
| Consolidated Income | -19.91M | ||
| Earnings per Basic Share | -2.08 | ||
| Earnings per Basic Share (USD) | -2.08 | ||
| Earnings per Diluted Share | -2.08 | ||
| Earning Before Interest & Taxes (EBIT) | -19.91M | ||
| Earning Before Interest & Taxes (USD) | -19.91M | ||
| Weighted Average Shares | 9.58M | ||
| Weighted Average Shares Diluted | 9.58M | ||
| Balance Sheet | |||
| Cash and Equivalents | 38.50M | ||
| Cash and Equivalents (USD) | 38.50M | ||
| Trade and Non-Trade Receivables | 233.00K | ||
| Current Assets | 31.84M | ||
| Property, Plant & Equipment Net | 77.08M | ||
| Total Assets | 117.62M | ||
| Debt Current | 10.87M | ||
| Total Debt | 80.50M | ||
| Current Liabilities | 19.34M | ||
| Debt Non-Current | 69.63M | ||
| Total Liabilities | 91.12M | ||
| Accumulated Retained Earnings (Deficit) | -992.32M | ||
| Shareholders Equity | 26.50M | ||
| Shareholders Equity (USD) | 26.50M | ||
| Assets Non-Current | 85.78M | ||
| Total Debt (USD) | 80.50M | ||
| Liabilities Non-Current | 71.78M | ||
| Trade and Non-Trade Payables | 2.34M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.04M | ||
| Net Cash Flow from Financing | 428.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -15.93M | ||
| Issuance (Purchase) of Equity Shares | 428.00K | ||
| Net Cash Flow from Operations | -16.36M | ||
| Share Based Compensation | 1.77M | ||